FDA OKs New Drug Saphris for Schizophrenia, Bipolar I Disorder

FDA OKs New Schizophrenia, Bipolar Drug Saphris Trumps Placebo at Reducing Symptoms of Schizophrenia, Bipolar Disorder WebMD Health News By Miranda Hitti Reviewed by Louise Chang, MD More from WebMD...

Click here to read the full story.

Post a Comment

No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.